These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 10478842)

  • 1. Transcriptional activation of c-fos protooncogene by 17beta-estradiol: mechanism of aryl hydrocarbon receptor-mediated inhibition.
    Duan R; Porter W; Samudio I; Vyhlidal C; Kladde M; Safe S
    Mol Endocrinol; 1999 Sep; 13(9):1511-21. PubMed ID: 10478842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular mechanism of inhibition of estrogen-induced cathepsin D gene expression by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in MCF-7 cells.
    Krishnan V; Porter W; Santostefano M; Wang X; Safe S
    Mol Cell Biol; 1995 Dec; 15(12):6710-9. PubMed ID: 8524236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estrogen-induced c-fos protooncogene expression in MCF-7 human breast cancer cells: role of estrogen receptor Sp1 complex formation.
    Duan R; Porter W; Safe S
    Endocrinology; 1998 Apr; 139(4):1981-90. PubMed ID: 9528985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of estrogen-induced activity by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in the MCF-7 human breast cancer and other cell lines transfected with vitellogenin A2 gene promoter constructs.
    Nodland KI; Wormke M; Safe S
    Arch Biochem Biophys; 1997 Feb; 338(1):67-72. PubMed ID: 9015389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcriptional activation of cathepsin D gene expression by 17beta-estradiol: mechanism of aryl hydrocarbon receptor-mediated inhibition.
    Wang F; Samudio I; Safe S
    Mol Cell Endocrinol; 2001 Feb; 172(1-2):91-103. PubMed ID: 11165043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The aryl hydrocarbon receptor (AHR)/AHR nuclear translocator (ARNT) heterodimer interacts with naturally occurring estrogen response elements.
    Klinge CM; Bowers JL; Kulakosky PC; Kamboj KK; Swanson HI
    Mol Cell Endocrinol; 1999 Nov; 157(1-2):105-19. PubMed ID: 10619402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular mechanism of inhibitory aryl hydrocarbon receptor-estrogen receptor/Sp1 cross talk in breast cancer cells.
    Khan S; Barhoumi R; Burghardt R; Liu S; Kim K; Safe S
    Mol Endocrinol; 2006 Sep; 20(9):2199-214. PubMed ID: 16675542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of a motif within the 5' regulatory region of pS2 which is responsible for AP-1 binding and TCDD-mediated suppression.
    Gillesby BE; Stanostefano M; Porter W; Safe S; Wu ZF; Zacharewski TR
    Biochemistry; 1997 May; 36(20):6080-9. PubMed ID: 9166778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanism of action of alpha-naphthoflavone as an Ah receptor antagonist in MCF-7 human breast cancer cells.
    Merchant M; Krishnan V; Safe S
    Toxicol Appl Pharmacol; 1993 Jun; 120(2):179-85. PubMed ID: 8390116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dioxin and estrogen signaling in lung adenocarcinoma cells with different aryl hydrocarbon receptor/estrogen receptor α phenotypes.
    Kuo LC; Cheng LC; Lin CJ; Li LA
    Am J Respir Cell Mol Biol; 2013 Dec; 49(6):1064-73. PubMed ID: 23855798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estrogen does not inhibit 2,3,7, 8-tetrachlorodibenzo-p-dioxin-mediated effects in MCF-7 and Hepa 1c1c7 cells.
    Hoivik D; Willett K; Wilson C; Safe S
    J Biol Chem; 1997 Nov; 272(48):30270-4. PubMed ID: 9374512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiestrogenic effect of 2,3,7,8-tetrachlorodibenzo-p-dioxin on 17 beta-estradiol-induced pS2 expression.
    Zacharewski TR; Bondy KL; McDonell P; Wu ZF
    Cancer Res; 1994 May; 54(10):2707-13. PubMed ID: 8168101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of the aryl hydrocarbon receptor and aryl hydrocarbon responsiveness in human ovarian carcinoma cell lines.
    Rowlands C; Krishnan V; Wang X; Santostefano M; Safe S; Miller WR; Langdon S
    Cancer Res; 1993 Apr; 53(8):1802-7. PubMed ID: 8385571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of zebra fish aromatase cyp19a and cyp19b genes in response to the ligands of estrogen receptor and aryl hydrocarbon receptor.
    Cheshenko K; Brion F; Le Page Y; Hinfray N; Pakdel F; Kah O; Segner H; Eggen RI
    Toxicol Sci; 2007 Apr; 96(2):255-67. PubMed ID: 17234648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of prolactin receptor gene expression by 2,3,7,8-tetrachlorodibenzo-p-dioxin in MCF-7 human breast cancer cells.
    Lu YF; Sun G; Wang X; Safe S
    Arch Biochem Biophys; 1996 Aug; 332(1):35-40. PubMed ID: 8806706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aryl hydrocarbon receptor-mediated inhibition of LNCaP prostate cancer cell growth and hormone-induced transactivation.
    Morrow D; Qin C; Smith R; Safe S
    J Steroid Biochem Mol Biol; 2004 Jan; 88(1):27-36. PubMed ID: 15026081
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional and physical interactions between the estrogen receptor Sp1 and nuclear aryl hydrocarbon receptor complexes.
    Wang F; Hoivik D; Pollenz R; Safe S
    Nucleic Acids Res; 1998 Jun; 26(12):3044-52. PubMed ID: 9611253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The ligand status of the aromatic hydrocarbon receptor modulates transcriptional activation of BRCA-1 promoter by estrogen.
    Hockings JK; Thorne PA; Kemp MQ; Morgan SS; Selmin O; Romagnolo DF
    Cancer Res; 2006 Feb; 66(4):2224-32. PubMed ID: 16489025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estrogen and aryl hydrocarbon receptor expression and crosstalk in human Ishikawa endometrial cancer cells.
    Wormke M; Castro-Rivera E; Chen I; Safe S
    J Steroid Biochem Mol Biol; 2000 Apr; 72(5):197-207. PubMed ID: 10822009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aryl hydrocarbon receptor-dependent inhibition of AP-1 activity by 2,3,7,8-tetrachlorodibenzo-p-dioxin in activated B cells.
    Suh J; Jeon YJ; Kim HM; Kang JS; Kaminski NE; Yang KH
    Toxicol Appl Pharmacol; 2002 Jun; 181(2):116-23. PubMed ID: 12051995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.